Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 70

Time Restricted Eating for Patients with Sleep Apnea

Official title: The Time Restricted Eating in Sleep Apnea Study

Run by University of California, San Diego · NCT06047496 · Data updated 2026-11-12

This study is testing if a new eating schedule can help people with sleep apnea improve their metabolism and overall health.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations1 site (La Jolla, California)
StatusRecruiting
StartedJanuary 5, 2024
Main results expectedJuly 2027
Study endsDecember 2028
Registry record updatedJanuary 16, 2024
Trial IDNCT06047496 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-70 with untreated moderate to severe obstructive sleep apnea and a baseline eating period of at least 12 hours per day.

Probably not a fit

Patients with diabetes requiring insulin or sulfonylureas, or those with significant sleepiness due to OSA may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of time restricted eating (TRE) on metabolic dysfunction in patients with obstructive sleep apnea (OSA). Participants will undergo a baseline period where they will log their dietary intake using a mobile app and wear a continuous glucose monitor. Following this, they will be randomized to implement TRE to assess its impact on glucose and lipid metabolism. The study aims to provide insights into alternative therapies for managing metabolic issues associated with OSA.

Why it matters

Potential benefit: If successful, this approach could improve metabolic health and overall quality of life for patients with obstructive sleep apnea.

How similar studies have gone: While some human studies have shown improvements in metabolic dysfunction with time restricted eating, this specific application in OSA has not been previously examined.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provision of signed and dated informed consent form;
* Stated willingness to comply with all study procedures and availability for the duration of the study;
* Be of appropriate age (18-70);
* Own a smartphone (Apple iOS or Android OS);
* Have a baseline eating period ≥12 hours/day and sufficient logging on the myCircadianClock app;
* If participants are on cardiovascular medications (HMG CoA reductase inhibitors (statins), other lipid-modifying drugs, anti-hypertensives) no dose adjustments will be allowed during the study period;
* Have untreated moderate to severe obstructive sleep apnea (OSA, apnea-hypopnea index ≥15 events/hr); and
* Agree to adhere to Lifestyle Considerations (see section 5.3) throughout study duration\]

Exclusion Criteria:

* Participants with type 1 or type 2 diabetes mellitus who are taking insulin or sulfonylureas, or any participant with a history of hypoglycemia unawareness
* OSA with evidence of significant sleepiness, as defined by either a) Epworth Sleepiness Score ≥15, or b) motor vehicle accident due to excessive sleepiness within the past year
* BMI \>40 kg/m2
* Uncontrolled hypertension
* Active tobacco or illicit drug use
* Pregnant or breastfeeding women
* Currently enrolled in a weight-loss or weight-management program
* Currently on a special or prescribed diet for other reasons (e.g., Celiac disease)
* Currently taking any medication that is meant for weight loss, or has known effect on appetite suppression
* History of eating disorder(s)
* History of surgical intervention for weight management
* Chronic kidney disease
* Treatment for active inflammatory and/or rheumatologic disease and cancer
* Unrevascularized cardiovascular disease
* Liver cirrhosis and/or significant alterations in liver function
* History of (a) thyroid disease requiring dose titration of thyroid replacement medication(s) within the past 3 months (i.e., hypothyroidism on a stable dose of thyroid replacement therapy is not an exclusion)
* Shift workers with variable (e.g., occasionally nocturnal) hours
* Traveling outside the US
* History of HIV/AIDS
* Uncontrolled psychiatric disorder
* Other safety concern based on MD judgement

Where it's running

  • University of California San Diego (ACTRI)
    La Jolla, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.